Inogen Inc Annual Deferred Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Inogen Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Inogen Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$201K.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$251K.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2021 was $14.4M.
  • Inogen Inc annual Deferred Income Tax Expense (Benefit) for 2020 was -$82K, a 103% decline from 2019.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$251K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2021 $14.4M +$14.5M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-01
2020 -$82K -$2.96M -103% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $2.87M +$14.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$11.6M -$19.5M -246% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $7.95M +$6.91M +667% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $1.04M -$3.72M -78.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $4.76M +$3.2M +204% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $1.56M +$23.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$21.8M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.